Search
Close this search box.
Search

Category: Press Releases

CGTN: Xizang’s development is a story of transformation and renewal

CGTN: Xizang’s development is a story of transformation and renewal CGTN: Xizang’s development is a story of transformation and renewalBEIJING, Aug. 19, 2025 (GLOBE NEWSWIRE) — The story of today’s Xizang Autonomous Region can’t be told in isolation. The profound transformation, resilience and renewal that people see today are a stark departure from the dark legacy of serfdom. It is a testament to the power of development guided by people-centered governance. Once, at a two-day high-level meeting, Chinese President Xi Jinping called for further efforts to ensure national security and enduring peace and stability, steadily improve people’s lives, maintain a

24/7 concierge: Zoom’s agentic AI and virtual agent now extends to Zoom Phone, helping businesses capture more calls and opportunities

Zoom Virtual Agent expands to Zoom Phone, enabling a new concierge use case that delivers personalized support with agentic concierge capabilities to automate routine calls and streamline frontline service across departments Zoom AI Companion enhances agentic scheduling to coordinate meetings end-to-end, finding the best time, contacting attendees, tracking responses, and recommending next steps without the back-and-forth Zoom Hub launches, providing a centralized workspace to create, find, and manage Zoom files Zoom Team Chat adds AI Companion to mobile for easier catch-up, and quick document summaries without needing to open the file in the Zoom Workplace desktop app, saving time and

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AG Bahnhof Park 4 6340, Baar, Switzerland Media Relations Contact Madhu Marur [email protected] Press Release Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced the launch of Fluorouracil Cream, 0.5%, an authorized generic and therapeutic equivalent of Carac® (fluorouracil cream) 0.5%, in the US market, approved by the

Lantronix Solution Powers U.S. Army-Approved Teal Drones, a Red Cat Holdings Co., Unlocking Secure Edge AI Growth Opportunity

Lantronix Enables TAA- and NDAA-Compliant Edge AI Solution, Supporting Sensitive U.S. Government Missions and Expanding Long-Term Defense Market Positioning IRVINE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that its TAA- and NDAA-compliant solution was selected by Teal Drones, a Red Cat Holdings Inc. (NASDAQ: RCAT) company, for production of its Black Widow drones under the U.S. Army’s Short-Range Reconnaissance (SRR) Program. Lantronix has already initiated production shipments, providing early revenue visibility and underscoring Lantronix’s role as a trusted technology partner for

Trident Announces Strategic Investment in Web 3.0 E-Commerce Firm Tongxin Innovation Limited

Trident’s 30% Stake in the Operator of a Telegram-Based Web 3.0 E-Commerce Platform Expands its Ecosystem and Capabilities, Providing Another Future Growth Catalyst SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) — Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a Singapore-based catalyst for digital transformation and Web 3.0 activation, today announced it has entered into a definitive sales and purchase agreement (the “SPA”) to acquire a 30% equity stake in Tongxin Innovation Limited (“Tongxin”), operator of the innovative ToMe Web 3.0 e-commerce platform on Telegram. The proposed transaction, valued at approximately US$3 million, will be completed through the

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025 EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025 ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) — EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address mislabelling and its link to antimicrobial resistance (AMR). A Global Call to Action Antibiotic allergy mislabelling affects millions worldwide. Inaccurate labels lead to avoidance of first-line treatments and overuse of second-line antibiotics, fuelling AMR. EAACI calls on all stakeholders to promote accurate diagnosis and responsible antibiotic use. “We are